1. A Vaccine Based on the Receptor-Binding Domain of the Spike Protein Expressed in Glycoengineered Pichia pastoris Targeting SARS-CoV-2 Stimulates Neutralizing and Protective Antibody Responses
- Author
-
Zhang Jun, Ying Yin, Junjie Xu, Yangqin Ou, Gong Xin, Qian Ke, Peng Sun, Tiantian Wang, Yuxiao Liu, Xuchen Hou, Hongguang Ren, Yongming Yao, Bo Liu, Jun Wu, and Shiqiang Luo
- Subjects
chemistry.chemical_classification ,Environmental Engineering ,Glycosylation ,General Computer Science ,biology ,Materials Science (miscellaneous) ,General Chemical Engineering ,Protein subunit ,General Engineering ,Energy Engineering and Power Technology ,biology.organism_classification ,medicine.disease_cause ,Virology ,law.invention ,Pichia pastoris ,Titer ,chemistry.chemical_compound ,chemistry ,law ,biology.protein ,Recombinant DNA ,medicine ,Antibody ,Glycoprotein ,Coronavirus - Abstract
In 2020 and 2021, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, caused a global pandemic. Vaccines are expected to reduce the pressure of prevention and control, and have become the most effective strategy to solve the pandemic crisis. SARS-CoV-2 infects the host by binding to the cellular receptor angiotensin converting enzyme 2 (ACE2) via the receptor-binding domain (RBD) of the surface spike (S) glycoprotein. In this study, a candidate vaccine based on a RBD recombinant subunit was prepared by means of a novel glycoengineered yeast Pichia pastoris expression system with characteristics of glycosylation modification similar to those of mammalian cells. The candidate vaccine effectively stimulated mice to produce high-titer anti-RBD specific antibody. Furthermore, the specific antibody titer and virus-neutralizing antibody (NAb) titer induced by the vaccine were increased significantly by the combination of the double adjuvants Al(OH)3 and CpG. Our results showed that the virus-NAb lasted for more than 6 months in mice. To summarize, we have obtained a SARS-CoV-2 vaccine based on the RBD of the S glycoprotein expressed in glycoengineered Pichia pastoris, which stimulates neutralizing and protective antibody responses. A technical route for fucose-free complex-type N-glycosylation modified recombinant subunit vaccine preparation has been established.
- Published
- 2022
- Full Text
- View/download PDF